Delivery Order SPE2DB22D3301-SPE2DB25FX8LX

Award Date 1/15/25
Potential Completion Date 2/6/25
Potential Value $15K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the delivery of Erleada 60 mg tablets. The $7,306.27 firm-fixed-price delivery order has a completion date of November 12, 2024. The contract is not designated as a set-aside. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a broad range...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,352.49 Firm Fixed Price delivery order covers the supply of ERLEADA 240 MG TABLET medical products. The contract has an ultimate completion date of January 10, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical division, which serves as a...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,558.78 firm fixed-price delivery order is for ERLEADA 60 MG TABLET, a specialty pharmaceutical product. The contract has an ultimate completion date of January 6, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, provides $14,704.98 in firm fixed-price delivery orders for the supply of ERLEADA 240 MG Tablets to the Defense Logistics Agency (DLA). The contract has an ultimate completion date of March 24, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $14,213.74 Firm Fixed Price delivery order is for the medication ERLEADA 60 MG TABLET UU 120S. The contract has an ultimate completion date of September 7, 2023. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026, which serves as a...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the delivery of ERLEADA 60 MG TABLET UU 120S, a pharmaceutical product. The $7,306.27 firm fixed-price delivery order has a completion date of November 8, 2024 and was awarded on October 18, 2024. The contract is not designated with a set-aside. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is a $7,558.78 firm fixed-price delivery order for 4566584342 ERLEADA 60 MG TABLET UU 120S, with a completion date of December 23, 2024. Amerisourcebergen also holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corporation's Corporate Office Division. The $7,106.87 firm fixed-price delivery order is for the pharmaceutical product ERLEADA 240 MG TABLET UU 30S, with a completion date of September 16, 2024. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, and this award falls under the company's existing Indefinite...
This federal contract award is to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The $7,306.27 firm fixed-price delivery order is for the supply of ERLEADA 60 MG TABLET UU 120S, a pharmaceutical product, with a completion date of November 6, 2024. The contract has no set-aside designation, indicating open competition. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC)...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,975.02 Firm Fixed Price Delivery Order (SPE2DB20D2104|SPE2DB23FR48V) is for the supply of the medication Erleada 60 mg Tablet. The award has an ultimate completion date of January 11, 2023. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through...
  • SPE2DB22D3301
    Indefinite Delivery Contract
  • SPE2DB22D3301-SPE2DB25FX8LX
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $15,117.58 firm fixed-price delivery order is for the drug Erleada 60 mg tablet, with a completion date of February 6, 2025. The award is not designated under any set-aside program.

AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs.

These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies, serving the healthcare needs of military personnel, veterans, and other federal beneficiaries through a streamlined, comprehensive contracting mechanism.

Generated 4/17/25, 8:43 AM